Metra and Metformin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metra (phendimetrazine tartrate) and Metformin (metformin hydrochloride). Common drug interactions include sudden cardiac death among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Metra and Metformin. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Metra?

Metra has active ingredients of phendimetrazine tartrate. eHealthMe is studying from 505 Metra users. Check the latest studies of Metra.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,354 Metformin users. Check the latest studies of Metformin.



On Jul, 26, 2026

38 people who take Metra and Metformin together, and have interactions are studied.

Metra and Metformin drug interactions.

What are the common drug interactions of Metra and Metformin, by gender? *:

female:

  1. Sudden cardiac death
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Respiratory distress (difficulty in breathing)
  4. Chronic kidney disease
  5. Drug ineffective
  6. Myocardial fibrosis (a condition in which the heart's muscle cells are impaired)
  7. Pain
  8. Cell death
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Fatigue (feeling of tiredness)

male:

  1. Drug ineffective
  2. Sudden cardiac death
  3. Myocarditis (inflammation of heart muscle myocardium)
  4. Pain in extremity
  5. Sudden death
  6. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  7. Cardiac hypertrophy (thickening of the heart muscle)
  8. Cardiomyopathy (weakening of the heart muscle)
  9. Gait disturbance
  10. Hypersensitivity

What are the common drug interactions of Metra and Metformin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Sudden cardiac death
  2. Myocardial fibrosis (a condition in which the heart's muscle cells are impaired)
  3. Cell death
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Myocarditis (inflammation of heart muscle myocardium)
  6. Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)

30-39:

  1. Sudden cardiac death
  2. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  3. Cardiac hypertrophy (thickening of the heart muscle)
  4. Cardiomyopathy (weakening of the heart muscle)
  5. Myocardial fibrosis (a condition in which the heart's muscle cells are impaired)
  6. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  7. Myocarditis (inflammation of heart muscle myocardium)
  8. Sudden death

40-49:

  1. Chronic kidney disease
  2. Pulmonary embolism (blockage of the main artery of the lung)

50-59:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Respiratory distress (difficulty in breathing)
  3. Asthenia (weakness)
  4. Concussion (short loss of normal brain function in response to a head injury)
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Influenza
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Neuropathy peripheral (surface nerve damage)
  10. Pain

60+:

  1. Drug ineffective
  2. Chronic kidney disease
  3. Pain
  4. Pain in extremity
  5. Renal failure (kidney dysfunction)
  6. Decreased appetite
  7. Diarrhoea
  8. Drug effect decreased
  9. Gait disturbance
  10. Hypoaesthesia (reduced sense of touch or sensation)

What are the existing conditions these people have? *

  1. Weight Loss: 11 people, 28.95%
  2. High Blood Pressure: 10 people, 26.32%
  3. Pain: 8 people, 21.05%
  4. High Blood Cholesterol: 7 people, 18.42%
  5. Stress And Anxiety: 7 people, 18.42%
  6. Neuralgia (pain in one or more nerves): 6 people, 15.79%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 15.79%
  8. Type 2 Diabetes: 5 people, 13.16%
  9. Indigestion: 5 people, 13.16%
  10. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 5 people, 13.16%

* Approximation only. Some reports may have incomplete information.

Do you take Metra and Metformin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Metra and Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metformin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phendimetrazine tartrate and metformin hydrochloride (the active ingredients of Metra and Metformin, respectively), and Metra and Metformin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: